Lava Therapeutics
(NASDAQ) LVTX
Lava Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$4.99M
Net Income (TTM)
$23.28M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
LVTX News
LVTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lava Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
34
CEO
Stephen Allen Hurly, MBA
Website
www.lavatherapeutics.comHeadquarters
Utrecht, 3584 CM, NL
LVTX Financials
Key Financial Metrics (TTM)
Gross Margin
-4%
Operating Margin
-6%
Net Income Margin
-5%
Return on Equity
-1%
Return on Capital
-62%
Return on Assets
-45%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$11.98M
Operating Income
$29.69M
EBITDA
$23.50M
Operating Cash Flow
$19.54M
Capital Expenditure
$23.00K
Free Cash Flow
$19.57M
Cash & ST Invst.
$76.58M
Total Debt
$5.28M
Lava Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
34
N/A
Net Income
$7.19M
+41.5%
EBITDA
$7.18M
+33.9%
Quarterly Fundamentals
Net Cash
$49.66M
-31.6%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-44.83%
N/A
Return on Invested Capital
-61.92%
N/A
Free Cash Flow
$4.87M
+43.7%
Operating Cash Flow
$4.87M
+43.6%